News Focus
News Focus
icon url

TOB

12/14/14 10:59 PM

#82503 RE: slcimmuno #82500

Thanks. I left a comment on the Forbes article pointing out the Top-line results and the QIDP, and that bottom-line data is expected this month. May click the email link to follow-up.

http://www.forbes.com/sites/davidkroll/2014/06/20/antibiotic-pipeline-revival-fda-approves-cubist-pharmaceuticals-sivextro-for-mrsa-other-serious-skin-infections/

A news article in a national and we may see some serious interest in CTIX.